Oxalic Acid as a Uremic Toxin

Journal of Renal Nutrition

Volumn 18, Issue 1, 2008, Pages 33-39

  Mydlík, Miroslav ^a   Derzsiová, Katarína ^b  

^a P J AFÁRIK UNIVERSITY   (Slovakia)

^b Logman as   (Slovakia)

Author keywords

[No Author keywords available]

Indexed keywords

ASCORBIC ACID; CREATININE; OXALIC ACID; PYRIDOXINE;

ADULT; ARTICLE; ATHEROSCLEROSIS; BLOOD; CHEMICALLY INDUCED DISORDER; CHRONIC KIDNEY FAILURE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FEMALE; GLOMERULONEPHRITIS; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PHYSIOLOGY; RENAL REPLACEMENT THERAPY; UREMIA;

ADULT; ASCORBIC ACID; ATHEROSCLEROSIS; CREATININE; FEMALE; GLOMERULONEPHRITIS; HUMANS; KIDNEY DISEASES; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; OXALIC ACID; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY; RENAL DIALYSIS; UREMIA; VITAMIN B 6;

EID: 37049013277     PISSN: 10512276     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.jrn.2007.10.008     Document Type: Article

References (35)

1. Castello J.F., Smith M., Stolarski C., et al. Extrarenal clearance of oxalate increases with progression of renal failure in the rat. J Am Soc Nephrol 3 (1992) 1098-1104
2. France N.C., Holland P.T., and Wallace M.R. Contribution of dialysis to endogenous oxalate production in patients with chronic renal failure. Clin Chem 40 (1994) 1544-1548
3. Massry S.G., and Glassock R.J. Textbook of nephrology. 3rd ed. (1995), Williams & Wilkins, Baltimore
4. Worcester E.M., Fellner S.K., Nakagawa Y., et al. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron 67 (1994) 414-418
5. Hatch M., Free R.W., and Vaziri N.D. Intenstinal excretion of oxalate in chronic renal failure. J Am Soc Nephrol 5 (1994) 1339-1343
6. Vanholder R., Argiles A., Baurmeister U., et al. Uremic toxicity: present state of the art. Int J Artif Organs 24 (2001) 695-725
7. Vanholder R., De Smet R., Glorieux G., et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 63 (2003) 1934-1943
8. Levin R.I., Kantoff P.W., and Jaffe E.A. Uremic levels of oxalic acid suppress replication and migration of human endothelial cells. Atherosclerosis 10 (1990) 198-207
9. Wills M.R. Uremic toxins, and their effect on intermediary metabolism. Clin Chem 31 (1985) 5-13
10. Boer P., van Leersum L., Hene R.J., et al. Plasma oxalate concentration in chronic renal disease. Am J Kidney Dis 4 (1984) 118-122
11. Salyer W.R., and Keren D. Oxalosis as a complication of chronic renal failure. Kidney Int 4 (1973) 61-66
12. Celasun B., Safali M., and Yenicesu M. Secondary oxalosis of bone in a dialysis patient. Scand J Urol Nephrol 29 (1995) 211-214
13. Nakazawa R., Hamaguchi K., Hosaka E., et al. Cutaneous oxalate deposition in a hemodialysis patient. Am J Kidney Dis 25 (1995) 492-497
14. Mydlík M., Derzsiová K., Sulková S., et al. Peritoneal clearance and peritoneal transfer of oxalic and ascorbic acid during continuous ambulatory peritoneal dialysis (CAPD). Akt Nefrol 1 (1995) 25-28
15. Makoff R. Vitamins replacement therapy in renal failure patients. Miner Electrolyte Metab 25 (1999) 349-351
16. Schück O. Fractional sodium excretion in patients with chronic renal failure with respect to the therapy. Nephron 30 (1982) 95-96
17. Schück O. Nephrology for practical doctors of medicine. 1st ed. (1993), Scientia Medica, Prague pp 156-158
18. Hořejší J., Fassati M., Jícha J., et al. Fundamentals of chemical investigations in medicine. 6th ed. (1964), Státní Zdravotnické Nakladatelství, Prague pp 538-540
19. Rolton H.A., McConnell K.N., Modi K.S., et al. A simple, rapid assay for plasma oxalate in uraemic patients using oxalate oxidase, which is free from vitamin C interference. Clin Chim Acta 182 (1989) 247-254
20. Krämer B., Pickert A., Hohmann C., et al. In vivo clearance and elimination of nine marker substances during hemofiltration with different membranes. Int J Artif Organs 15 (1992) 408-412
21. Mydlík M., Derzsiová K., Pribylincová V., et al. Urinary excretion of oxalic acid in chronic renal failure and after kidney transplantation. Przegl Lek 53 Suppl 3 (1996) 65-69
22. 6, oxalic acid and vitamin C in chronic renal failure. Miner Electrolyte Metab 25 (1999) 352-356
23. 6 during continuous ambulatory peritoneal dialysis. Artif Organs 22 (1998) 784-788
24. Mydlík M., and Derzsiová K. Renal replacement therapy and secondary hyperoxalaemia in chronic renal failure. Kidney Int 59 Suppl 78 (2001) 304-307
25. Marangella M., Vitale C., Petrarulo M., et al. The clinical significance of assessment of serum calcium oxalate saturation in the hyperoxaluria syndromes. Nephrol Dial Transplant 10 Suppl 8 (1995) 11-13
26. Wahl R., and Kallee E. Oxalic acid in saliva, teeth and tooth tartar. Eur J Clin Chem Clin Biochem 32 (1994) 821-825
27. Mäkilä E. Salivary vitamins. Int Z Vit Forsch 38 (1968) 260-269
28. Mäkilä E., and Kirveskari P. A study of ascorbic acid in human saliva. Arch Oral Biol 14 (1969) 1285-1292
29. Bates J.F., Hughes R.E., and Hurley R.J. Ascorbic acid status in man: measurements of salivary, plasma and white blood cell concentration. Arch Oral Biol 17 (1972) 1017-1020
30. Mydlík M., Derzsiová K., Jenča A., et al. Salivary oxalic acid and ascorbic acid in chronic renal failure. In: Trevino-Becera A., Pineda-Sanches E., and Trinida-Ramos P. (Eds). Proceedings selected papers of the XIII International Congress on Nutrition and Metabolism in Renal Disease. Merida (Mexico) February 28-March 4, 2006 (2006), Medimond S.R.L., Bologna 39-44
31. In: Blacow N.W., and Wade A. (Eds). Martindale: the extra pharmacopoiea. 26th ed. (1972), Pharmaceutical Press, London
32. Dzúrik R., and Dzúriková V. Diuretic therapy. 2nd ed. (1981), Martin, Osveta pp 18-20
33. Boer P., Beutler J.J., van Rijn H.J.M., et al. Urinary oxalate excretion during intravenous infusion of diuretics in man. Nephron 54 (1990) 187-188
34. 6 in chronic renal failure. Vnitr Lek 44 (1998) 127-131
35. Dell'Aquilla R., Feriani M., Mascalzoni E., et al. Oxalate removal by differing dialysis techniques. ASAIO J 38 (1992) 797-800